358 related articles for article (PubMed ID: 8794712)
21. Ocular angiogenesis; a new in vivo experimental model.
Grignolo FM; Emanuelli L; Eandi CM; Brogliatti B
Acta Ophthalmol Scand Suppl; 1997; (224):10-1. PubMed ID: 9589706
[No Abstract] [Full Text] [Related]
22. [Comparison with indocyanine green angiography and immunohistochemical study of choroidal neovascular membrane in age-related macular degeneration].
Nakajima M; Shimada H; Sato M; Yuzawa M
Nippon Ganka Gakkai Zasshi; 1999 Mar; 103(3):252-8. PubMed ID: 10214061
[TBL] [Abstract][Full Text] [Related]
23. Expression of FGF5 in choroidal neovascular membranes associated with ARMD.
Kitaoka T; Morse LS; Schneeberger S; Ishigooka H; Hjelmeland LM
Curr Eye Res; 1997 Apr; 16(4):396-9. PubMed ID: 9134330
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization.
Spilsbury K; Garrett KL; Shen WY; Constable IJ; Rakoczy PE
Am J Pathol; 2000 Jul; 157(1):135-44. PubMed ID: 10880384
[TBL] [Abstract][Full Text] [Related]
25. Choroidal neovascularization complicating epiretinal membrane removal.
Korobelnik JF; Dureau P; Sarfati A; Chauvaud D; Hoang-Xuan T
Acta Ophthalmol Scand; 1997 Jun; 75(3):320-1. PubMed ID: 9253987
[TBL] [Abstract][Full Text] [Related]
26. Differential hypoxic response of human choroidal and retinal endothelial cells proposes tissue heterogeneity of ocular angiogenesis.
Mammadzada P; Gudmundsson J; Kvanta A; André H
Acta Ophthalmol; 2016 Dec; 94(8):805-814. PubMed ID: 27255568
[TBL] [Abstract][Full Text] [Related]
27. Consequences of verteporfin photodynamic therapy on choroidal neovascular membranes.
Tatar O; Kaiserling E; Adam A; Gelisken F; Shinoda K; Völker M; Lafaut BA; Bartz-Schmidt KU; Grisanti S
Arch Ophthalmol; 2006 Jun; 124(6):815-23. PubMed ID: 16769835
[TBL] [Abstract][Full Text] [Related]
28. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor.
Schmidt-Erfurth U; Schlötzer-Schrehard U; Cursiefen C; Michels S; Beckendorf A; Naumann GO
Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4473-80. PubMed ID: 14507895
[TBL] [Abstract][Full Text] [Related]
29. Immunohistopathologic evaluation of choroidal neovascular membranes following verteporfin-photodynamic therapy.
Grisanti S; Tatar O; Canbek S; Lafaut BA; Gelisken F; Inhoffen W; Szurman P; Aisenbrey S; Oficjalska-Mlynczak J; Bartz-Schmidt KU
Am J Ophthalmol; 2004 May; 137(5):914-23. PubMed ID: 15126158
[TBL] [Abstract][Full Text] [Related]
30. Well-defined subfoveal choroidal neovascular membranes in age-related macular degeneration.
Lopez PF; Lambert HM; Grossniklaus HE; Sternberg P
Ophthalmology; 1993 Mar; 100(3):415-22. PubMed ID: 7681555
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor expression in choroidal neovascularization in rats.
Yi X; Ogata N; Komada M; Yamamoto C; Takahashi K; Omori K; Uyama M
Graefes Arch Clin Exp Ophthalmol; 1997 May; 235(5):313-9. PubMed ID: 9176680
[TBL] [Abstract][Full Text] [Related]
32. Proliferation and activation of vascular endothelial cells in epiretinal membranes from patients with proliferative diabetic retinopathy. An immunohistochemistry and clinical study.
Tang S; Le-Ruppert KC; Gabel VP
Ger J Ophthalmol; 1994 May; 3(3):131-6. PubMed ID: 7518716
[TBL] [Abstract][Full Text] [Related]
33. [Correlation of pathological features of surgically excised choroidal neovascular membranes with age-related macular degeneration and indocyanine green videoangiographic findings].
Ishikawa K; Ebisawa N; Kamada K; Yoneya S
Nippon Ganka Gakkai Zasshi; 1998 Mar; 102(3):179-88. PubMed ID: 9558840
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-I and its receptor in neovascular age-related macular degeneration.
Lambooij AC; van Wely KH; Lindenbergh-Kortleve DJ; Kuijpers RW; Kliffen M; Mooy CM
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2192-8. PubMed ID: 12714661
[TBL] [Abstract][Full Text] [Related]
35. Treatment of foveal pigment epithelial detachments with contiguous extrafoveal choroidal neovascular membranes.
Maguire JI; Benson WE; Brown GC
Am J Ophthalmol; 1990 May; 109(5):523-9. PubMed ID: 1692183
[TBL] [Abstract][Full Text] [Related]
36. Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium.
Schwesinger C; Yee C; Rohan RM; Joussen AM; Fernandez A; Meyer TN; Poulaki V; Ma JJ; Redmond TM; Liu S; Adamis AP; D'Amato RJ
Am J Pathol; 2001 Mar; 158(3):1161-72. PubMed ID: 11238064
[TBL] [Abstract][Full Text] [Related]
37. Angiogenic factors in human proliferative sickle cell retinopathy.
Cao J; Mathews MK; McLeod DS; Merges C; Hjelmeland LM; Lutty GA
Br J Ophthalmol; 1999 Jul; 83(7):838-46. PubMed ID: 10381672
[TBL] [Abstract][Full Text] [Related]
38. A comparison of hypoxia-inducible factor-α in surgically excised neovascular membranes of patients with diabetes compared with idiopathic epiretinal membranes in nondiabetic patients.
Lim JI; Spee C; Hinton DR
Retina; 2010 Oct; 30(9):1472-8. PubMed ID: 20811317
[TBL] [Abstract][Full Text] [Related]
39. [Effective mechanisms of laser photocoagulation for neovascularization in diabetic retinopathy].
Funatsu H; Hori S; Yamashita H; Kitano S
Nippon Ganka Gakkai Zasshi; 1996 May; 100(5):339-49. PubMed ID: 8651051
[TBL] [Abstract][Full Text] [Related]
40. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate.
Tolentino MJ; Miller JW; Gragoudas ES; Jakobiec FA; Flynn E; Chatzistefanou K; Ferrara N; Adamis AP
Ophthalmology; 1996 Nov; 103(11):1820-8. PubMed ID: 8942877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]